covid vaccine - Search News

Order byBest matchMost fresh

FDA, Covid and vaccine

FDA picks a new strain for fall Covid vaccines. Here's what it means for your next shot.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most at-risk Americans this fall.

· 2h · on MSN

· 2d · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

· 1d · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

FDA panel recommends keeping COVID shots targeted to same strain as last year

Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

STAT · 4h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 5h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

1don MSN

Changes are happening around COVID-19 vaccines: Here's what to know

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

21hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

2don MSN

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

Growth Serum: Reinventing the world’s largest Covid vaccine supplier

In India, the most prominent symbol of the Covid response was the Serum Institute of India. The company became the world’s largest Covid vaccine supplier (Covishield), propelling it, and CEO Adar Poonawalla, to record revenues and global recognition.

Explore more

Trump

Food and Drug Administration

Novavax

Pfizer

Moderna

McKnight's Long-Term Care News16h

Therapy firm to pay in COVID vaccine religious-discrimination case

A rehab firm will pay a cash settlement to an occupational therapist it fired when the worker declined a COVID-19 vaccination.

mlive23h

COVID-19 booster eligibility may be changing. Michigan’s uptake was already low

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

F.D.A. Poised to Restrict Access to Covid Vaccines

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.